Memorandum Of Understanding Signed Between ICMR, NIAID, NIH-DHHS
- Vipin Kumar
- March 10, 2022
- News
A Memorandum of Understanding (MoU) is signed between (ICMR) Indian Council of Medical Research and (NIAID) the National Institute of Allergy and Infectious Diseases, (NIH DHHS) National Institute of Health of Department of Health and Human Services, US. This Memorandum of Understanding was approved by the Union Cabinet, chaired by Prime Minister Narendra Modi.
The cooperation will commence in Chennai, India, at NIRT (National Institute for Research on Tuberculosis) in the premise of ICMR. The research includes other aspects as well, such as innovative research, medicine, epidemiology, medical entomology, immunology, microbiology, development of techniques of prevention, quick diagnosis and treatment of diseases from tropical infections to allergic diseases. The focus of this collaboration includes scientific developments and research of diseases like tuberculosis, HIV/AIDS, parasitic infection, immune system diseases, allergic diseases, new emerging and re-emerging diseases and other diseases that need special scientific attention.
Financial support to the cooperation will be provided by the US and the Indian Governments, this funding will support research and activities under the MoU. The cooperation is also allowed to seek funds from other non-government organisations, private sectors and foundations that share the same perceptive or are interested in non-profitable funding. It is said that the projects would be conducted in accordance with the need, and all the activities inside the collaboration will abide by the law and willfully follow all regulations, policies and guidelines prevailing in the nation.
The primary purpose of the research team is to generate employment for Indian researchers, scientists and students. While the projects will commence under MoU collaboration, they will work on developing the best treatment options for emerging and re-emerging serious diseases like immune system disease, allergic infections, etc.